Cerebrolysin vs KPV
Overview
Cerebrolysin is primarily a cognitive enhancement peptide, while KPV is used for immune support.
This page compares Cerebrolysin and KPV across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Cerebrolysin | KPV | |
|---|---|---|
| Category | Cognitive Enhancement | Immune Support |
| Regulatory status (US) | Research use only | Compounding (Rx) — Apr 2026 |
| Typical dosage | 5-10 ml | 500-1000 mcg |
| Frequency | multiple times weekly | daily |
| Reported benefits | Neuroprotection, stroke recovery support, cognitive improvement, neurodegenerative disease support | Reduces inflammation, immune modulation, gut health support |
| Reported side effects | Generally well-tolerated. Possible: dizziness, agitation | Very well-tolerated |
Key differences
Primary use. Cerebrolysin is categorised under Cognitive Enhancement, while KPV falls under Immune Support. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Cerebrolysin: not FDA-approved; treated as a research compound. KPV: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Cerebrolysin is typically dosed at 5-10 ml (multiple times weekly). KPV is typically dosed at 500-1000 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Cerebrolysin and KPV has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Cerebrolysin and KPV?
- Cerebrolysin is primarily a cognitive enhancement peptide, while KPV is used for immune support. Cerebrolysin is not FDA-approved; generally classified as a research compound, whereas KPV is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Cerebrolysin used for?
- Neuroprotection, recovery.
- What is KPV used for?
- Anti-inflammatory immune peptide.
- Can you take Cerebrolysin and KPV together?
- Some users combine peptides within a single protocol, but stacking Cerebrolysin and KPV has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Cerebrolysin or KPV FDA-approved?
- Cerebrolysin is not FDA-approved; generally classified as a research compound. KPV is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Cerebrolysin — full monograph: mechanism, research, dosing & references
- KPV — full monograph: mechanism, research, dosing & references